Abstract
Cancer stem cells (CSCs) are cancer cells with characteristics of stem cells, especially the ability to arise to all types of cell in a particular cancer tissue. With the capacity to generate multiple types of cancer cells, CSCs are proposed as primary impetus for tumor initiation and metastases and are suggested as potential therapeutic targets for anti-cancer treatment. Peroxisome-proliferatoractivated receptors (PPARs) are a subset of multifunctional transcription factors which play a pivotal role in cancer development and tumorigenesis. PPARs are also reported to be involved in the modulation of the epithelial-mesenchymal transition (EMT) process in CSC initiation and in the regulation of CSC functions. However, the exact mechanisms remain unknown. Herein, we review the latest evidence on the regulatory effects and mechanisms of PPARs in CSC formation and function, and evaluate the prospects of PPARs as a target for cancer treatment.
Keywords: Cancer, cancer stem cells, EGF/bFGF signaling pathway, epithelial-mesenchymal transition, peroxisomeproliferator- activated receptors, Sonic hedgehog signaling pathway.
Current Stem Cell Research & Therapy
Title:Expression and Function of PPARs in Cancer Stem Cells
Volume: 11 Issue: 3
Author(s): Yiming Zhang, Xu Zhang, Jing Wang, Yun Shen, Xiaoshan Tang, Fang Yu and Raorao Wang
Affiliation:
Keywords: Cancer, cancer stem cells, EGF/bFGF signaling pathway, epithelial-mesenchymal transition, peroxisomeproliferator- activated receptors, Sonic hedgehog signaling pathway.
Abstract: Cancer stem cells (CSCs) are cancer cells with characteristics of stem cells, especially the ability to arise to all types of cell in a particular cancer tissue. With the capacity to generate multiple types of cancer cells, CSCs are proposed as primary impetus for tumor initiation and metastases and are suggested as potential therapeutic targets for anti-cancer treatment. Peroxisome-proliferatoractivated receptors (PPARs) are a subset of multifunctional transcription factors which play a pivotal role in cancer development and tumorigenesis. PPARs are also reported to be involved in the modulation of the epithelial-mesenchymal transition (EMT) process in CSC initiation and in the regulation of CSC functions. However, the exact mechanisms remain unknown. Herein, we review the latest evidence on the regulatory effects and mechanisms of PPARs in CSC formation and function, and evaluate the prospects of PPARs as a target for cancer treatment.
Export Options
About this article
Cite this article as:
Zhang Yiming, Zhang Xu, Wang Jing, Shen Yun, Tang Xiaoshan, Yu Fang and Wang Raorao, Expression and Function of PPARs in Cancer Stem Cells, Current Stem Cell Research & Therapy 2016; 11 (3) . https://dx.doi.org/10.2174/1574888X10666150728122921
DOI https://dx.doi.org/10.2174/1574888X10666150728122921 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aberrant DNA Methylation and Prostate Cancer
Current Genomics Stem Cells and Combinatorial Science
Combinatorial Chemistry & High Throughput Screening Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Current Stem Cell Research & Therapy Intraperitoneal Drug Therapy: An Advantage
Current Clinical Pharmacology Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Current State of the Art of New Tubulin Inhibitors in the Clinic
Current Clinical Pharmacology Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Current Cancer Drug Targets Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer
Clinical Cancer Drugs Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options
Current Cancer Therapy Reviews Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs
Current Pharmacogenomics Implications of Photophysical and Physicochemical Factors on Successful Application of Photodynamic Therapy
Current Pharmaceutical Design Current Targets for Anticancer Drug Discovery
Current Drug Targets The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Airway Fibroblast Secretory Products Enhance Cell Migration
Current Proteomics The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Current Drug Targets Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Cancer Stem Cells and their Management in Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery